House passes bills to ease access to MAT,expand SOR

The House Energy and Commerce Committee passed 26 health bills on Sept. 9, including measures that would expand access to mental health services, combat the opioid epidemic, reauthorize key public health programs, improve Medicare enrollment, streamline public health data sharing for tribes and facilitate access to marijuana for research.     

HR软件推荐

已经举办两届的“e-HR在中国”峰会及展览会显示,从招聘到绩效考核.各种软件在人力资源管理中发挥着重要作用,把人力资源部门从烦琐的事务性工作中解放出来,让人力资源管理能与企业的战略发展保持更密切的联系。     

Long‐term use of methylphenidate continues to confer benefits

Patients continue to receive benefits from treatment for attention‐deficit/hyperactivity disorder (ADHD) with methylphenidate after long‐term use, researchers have found. Some patients may be withdrawn from the medication, however. Therefore, all patients should be assessed periodically to determine whether they continue to need the medication. The study, published in the American Journal of Psychiatry, was conducted because, while long‐term use of methylphenidate for children with ADHD is frequent clinical practice, its benefits are unclear. They looked at whether the medication remains beneficial after 2 years. Methylphenidate, a stimulant, has been controversial in some quarters because it is a controlled substance, However, the first‐line treatment for ADHD is psychostimulant medication, such as methylphenidate. How long children should take is is a question, but 60% of children receive stimulant treatment for ADHD for more than 2 years, and this is increasingly common, extending even into adolescence and adulthood. This is partly due to the awareness that ADHD is not a pediatric‐only condition. The study, “Continued benefits of methylphenidate in ADHD after 2 years in clinical practice: A randomized placebo‐controlled discontinuation study,” was published online May 21 by the American Journal of Psychiatry.